83. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Donnerstag, 20. April 2017 (Posterbereich 7) 14:30-16:00

Postervorträge

Periinterventionelle Therapie bei TAVI

Diskussionsleiter: P. M. Becher (Hamburg), T. Hofmann (Pinneberg)

(P729) NOAC mono therapy in patients with concomitant indications for oral anticoagulation undergoing transcatheter aortic valve replacement
    N. A. Geis, C. Kiriakou, E. Chorianopoulos, H. A. Katus, R. Bekeredjian (Heidelberg)
(P730) Valve performance and safety profile for oral anticoagulation after transfemoral aortic valve implantation
    F. Woitek, L. Crusius, N. Mangner, S. Haussig, G. Stachel, D. Holzhey, R. Höllriegel, F. W. Mohr, G. C. Schuler, A. Linke (Leipzig)
(P731) Predictors Of new heart block requiring pacemaker implantation in patients undergoing transcatheter aortic valve replacement (TAVR)
    J. Schewel, D. Schewel, M. Schlüter, F. Kreidel, T. Schmidt, H. Alessandrini, M. Schmoeckel, K.-H. Kuck, C. Frerker (Hamburg)
(P732) Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement
    P. Stachon, A. Gutmann, K. Kaier, H. Reinecke, A. Zirlik, C. von zur Mühlen, L. Frankenstein, M. Zehender, C. Bode, J. Reinöhl (Freiburg im Breisgau, Freiburg, Münster, Heidelberg)
(P733) Long-term follow-up after transcatheter aortic valve implantation and durability of transcatheter aortic valves - results of a prospective single center registry
    S. Haussig, C. Pleißner, M. Zimmer, N. Mangner, F. Woitek, S. Leontyev, D. Holzhey, F. W. Mohr, G. C. Schuler, A. Linke (Leipzig)
(P734) Prevalence and relevance of impaired left ventricular function in chronic moderate regurgitation of native aortic valves
    B. F. Gomes, B. Meder, D. Mereles, H. A. Katus, R. Bekeredjian (Heidelberg)